Document Detail

The feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study.
MedLine Citation:
PMID:  23139049     Owner:  NLM     Status:  Publisher    
PURPOSES: The benefit of neo-adjuvant chemotherapy for liver-limited metastatic colorectal cancer is still controversial. This study defined the resectability regardless of the size and number of liver metastases, and attempted curative hepatic resection in all cases. METHODS: Sixty-four patients that tolerated chemotherapy were diagnosed with CLM (colorectal liver metastases) without extrahepatic metastase from January 2007 to November 2010, and received an oxaliplatin-based regimen. This study assessed the resectability after chemotherapy, and the patients were divided in two groups; the resected and unresected group. Sixteen patients underwent hepatic resection without chemotherapy. RESULTS: Thirty-five patients underwent surgical resection (resected group) and twenty-nine patients were considered unresectable (unresected group). All 35 patients in the resected group safely received oxaliplatin-based chemotherapy safely without serious adverse effects. No serious postoperative complications were observed. The median overall survival (MST) was significantly higher in the resected than in the unresected group (56.93 [95 % CI 38.13-75.73] and 25.07 months [95 % CI 17.87-32.26], respectively; P < 0.001). The median disease-free survival was 20.2 [95 % CI 8.82-31.65] months in the resected group. CONCLUSION: Preoperative chemotherapy for CLM is well tolerated and does not increase postoperative complications. Curative surgery with preoperative chemotherapy has the potential to improve the overall survival in patients with CLM.
Kozo Kataoka; Akiyoshi Kanazawa; Akio Nakajima; Ayane Yamaguchi; Akira Arimoto; Yukihiro Kohno
Related Documents :
10561349 - Phase iii multicenter randomized trial of the dartmouth regimen versus dacarbazine in p...
8643249 - Primary orbital melanomas.
16778169 - Melanoma-reactive t cells in the bone marrow of melanoma patients: association with dis...
2064939 - Malignant melanoma occurring in those aged under 30 in the west of scotland 1979-1986: ...
16121769 - Adjuvant therapies in the treatment of stage ii and iii malignant melanoma.
8038589 - Is there an indication for a double perfusion schedule with melphalan for patients with...
15368329 - Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refracto...
18669719 - Gestational trophoblastic neoplasia: treatment outcomes.
18559599 - Rhamm, p21 combined phenotype identifies microsatellite instability-high colorectal can...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Surgery today     Volume:  -     ISSN:  1436-2813     ISO Abbreviation:  Surg. Today     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204360     Medline TA:  Surg Today     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Surgery, Osaka Red-Cross Hospital, 5-30, Fudegasaki, Tennnoji, Osaka, 543-8555, Japan,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intersphincteric resection for very low rectal cancer: a systematic review.
Next Document:  Chiral sulfoxides in the enantioselective allylation of aldehydes with allyltrichlorosilane: a kinet...